Stock Price

A small biotech is raising millions with a high-risk funding plan to launch a BOTOX alternative. Can it survive long enough to disrupt a pharma titan?

Safi Silver is slashing its warrant price and extending terms in a bold bid for capital, just as a key director resigns. What does this strategic shift mean?

Known for its automotive tech, Israeli firm Arbe Robotics lands a key defense deal, a strategic pivot leveraging its 4D radar for mission-critical security.

SaaS firm Youxin Technology signals a major pivot with a conditional investment in RiverBit, a DeFi platform aiming to trade tokenized US stocks 24/7 via AI agents.

The payment giant says operations are normal and refuses to pay hackers. But with business data and transaction records stolen, what is the true cost of defiance?

GAM's activist managers up their stake in Liontrust and target Impax, citing deep undervaluation and exposing fractures in a UK fund sector under pressure.

A class action lawsuit against Roblox is more than a legal battle. It signals the end of the digital economy's growth-at-all-costs era.

Rithm Property Trust is raising cash to buy multifamily loans from its own manager. Is this a savvy move in a tough market or a risky inside deal?

With a new CEO from the world of high-stakes mining finance, Entrée Resources signals a strategic pivot for its stake in the massive Oyu Tolgoi copper mine.

Commodities giant Glencore transforms a $25M loan into a major equity position in Osisko Metals, signaling a strong bet on Canadian critical minerals.

Eupraxia Pharmaceuticals is overhauling its leadership and relocating to major biotech hubs, betting it all on its late-stage pipeline and a pivotal trial.

Voyager Technologies' acquisition of Astrobotic was no accident. A new $298M NASA contract, secured just in time, reveals a masterstroke in the race for the Moon.

Alto Neuroscience's $100M raise fuels its quest to treat resistant depression. It's a high-stakes play on a biomarker-driven approach in a challenging field.

As BNB Plus Corp. falls from Nasdaq to the over-the-counter markets, its hybrid crypto-biotech model is under intense scrutiny. What does this mean for investors?

ProCap Financial's AI agent has amassed $50B in user assets, signaling a new era for investors. But beyond the hype, what are the real gains and risks?

Amid key technical wins like piloted transition, Vertical Aerospace delays its eVTOL certification, a move reflecting an industry-wide reality check.

With Aon's Q2 results imminent, investors are watching key metrics, strategic moves, and how the firm navigates a complex global risk landscape.

The Real Brokerage's bold merger with RE/MAX creates a new industry titan. But can an AI-driven, cloud-based culture truly integrate with a global franchise empire?

Beyond just a new logo, Chicago Rivet & Machine Co.'s rebrand signals a strategic shift from parts supplier to a systems expert for the next century.

With a historic $26.5B NASDAQ listing, SK hynix solidifies its crucial role in the AI supply chain, escalating the high-stakes race for memory dominance.